Figure 1From: CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)3D volume rendered reconstruction in a 4 day old neonate with interrupted aortic arch.Back to article page